Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study

American Heart Journal

Volumn 148, Issue 3, 2004, Pages 538-544

  Wachtell, Kristian ^a,b   Papademetriou, Vasilios ^c   Smith, Gunnar ^d   Gerdts, Eva ^e   Dahlöf, Björn ^f   Engblom, Erik ^g   Aurigemma, Gerard P ^h   Bella, Jonathan N ^b   Ibsen, Hans ^a   Rokkedal, Jens ^a   Devereux, Richard B ^b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY SIZE; COMPARATIVE STUDY; CORRELATION ANALYSIS; CORRELATION FUNCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEALTH PROGRAM; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE OVERLOAD; HUMAN; HYPERTENSION; HYPERTROPHY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; STRESS; TIME;

EID: 4644295705     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.03.015     Document Type: Article

References (38)

1. Kapuku G.K., Seto S., Mori H., et al. Impaired left ventricular filling in borderline hypertensive patients without cardiac structural changes. Am Heart J. 125:1993;1710-1716
2. Wachtell K., Smith G., Gerdts E., et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Am J Cardiol. 85:2000;466-472
3. Fouad Tarazi F.M., Tarazi R.C., Gallagher J.H., et al. Abnormal left ventricular relaxation in hypertensive patients. Clin Sci. 59:(Suppl 6):1980;411-414s
4. Inouye I., Massie B., Loge D., et al. Abnormal left ventricular filling an early finding in mild to moderate systemic hypertension. Am J Cardiol. 53:1984;120-126
5. Topol E.J., Traill T.A., Fortuin N.J. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med. 312:1985;277-283
6. Brilla C.G., Janicki J.S., Weber K.T. Impaired diastolic function and coronary reserve in genetic hypertension role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res. 69:1991;107-115
7. Blake J., Devereux R.B., Herrold E.M., et al. Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension. Am J Cardiol. 62:1988;246-252
8. de Simone G., Di Lorenzo L., Costantino G., et al. Supernormal contractility in primary hypertension without left ventricular hypertrophy. Hypertension. 11:1988;457-463
9. Wachtell K., Rokkedal J., Bella J.N., et al. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE Study). Am J Cardiol. 87:2001;54-60
10. de Simone G., Devereux R.B., Roman M.J., et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension [published erratum appears in J Am Coll Cardiol 1994;24:844]. J Am Coll Cardiol. 23:1994;1444-1451
11. de Simone G., Devereux R.B., Koren M.J., et al. Midwall left ventricular mechanics an independent predictor of cardiovascular risk in arterial hypertension. Circulation. 93:1996;259-265
12. Dahlöf B., Devereux R.B., Julius S., et al. Characteristics of 9194 patients with left ventricular hypertrophy the LIFE study. Hypertension. 32:1998;989-997
13. Dahlöf B., Devereux R.B., Kjeldsen S.E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) a randomised trial against atenolol. Lancet. 359:2002;995-1003
14. Wachtell K., Bella J.N., Liebson P.R., et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population the LIFE study. Hypertension. 35:2000;6-12
15. Devereux R.B., Roman M.J., Palmieri V., et al. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy the LIFE study. Losartan Intervention For Endpoint reduction in hypertension. J Hypertens. 18:2000;1129-1138
16. Devereux R.B., Alonso D.R., Lutas E.M., et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol. 57:1986;450-458
17. Reichek N., Devereux R.B. Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness identification of severe valvular aortic stenosis in adult patients. Am Heart J. 103:1982;202-209
18. Devereux R.B., Dahlöf B., Levy D., et al. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol. 78:1996;61-65
19. Ganau A., Devereux R.B., Roman M.J., et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 19:1992;1550-1558
20. Teichholz L.E., Kreulen T., Herman M.V., et al. Problems in echocardiographic volume determinations echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 37:1976;7-11
21. Roman M.J., Pickering T.G., Schwartz J.E., et al. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol. 25:1995;83-90
22. Gutgesell H.P., Paquet M., Duff D.F., et al. Evaluation of left ventricular size and function by echocardiography results in normal children. Circulation. 56:1977;457-462
23. Appleton C.P., Hatle L.K., Popp R.L. Relation of transmitral flow velocity patterns to left ventricular diastolic function new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol. 12:1988;426-440
24. Nishimura R.A., Appleton C.P., Redfield M.M., et al. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol. 28:1996;1226-1233
25. Dahlöf B., Devereux R.B., de Faire U., et al. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension Study. Am J Hypertens. 10:1997;705-713
26. Shimizu G., Hirota Y., Kita Y., et al. Left ventricular midwall mechanics in systemic arterial hypertension myocardial function is depressed in pressure- overload hypertrophy. Circulation. 83:1991;1676-1684
27. Shimizu G., Zile M.R., Blaustein A.S., et al. Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy overestimation of fiber velocities by conventional midwall measurements. Circulation. 71:1985;266-272
28. Bella J.N., Palmieri V., Liu J.E., et al. Relationship between left ventricular diastolic relaxation and systolic function in hypertension the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension. 38:2001;424-428
29. Schussheim A.E., Diamond J.A., Jhang J.S., et al. Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension. Am J Cardiol. 82:1998;1056-1059
30. Levy D., Larson M.G., Vasan R.S., et al. The progression from hypertension to congestive heart failure. JAMA. 275:1996;1557-1562
31. Wachtell K., Palmieri V., Olsen M.H., et al. Change in systolic left ventricular performance after 3 years of antihypertensive treatment the Losartan Intervention for Endpoint (LIFE) Study. Circulation. 106:2002;227-232
32. Wachtell K., Bella J.N., Rokkedal J., et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation. 105:2002;1071-1076
33. Casale P.N., Devereux R.B., Milner M., et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 105:1986;173-178
34. Levy D., Garrison R.J., Savage D.D., et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566
35. Koren M.J., Devereux R.B., Casale P.N., et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 114:1991;345-352
36. Ghali J.K., Liao Y., Simmons B., et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med. 117:1992;831-836
37. Poulsen S.H., Andersen N.H., Ivarsen P.I., et al. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction. J Am Soc Echocardiogr. 16:2003;724-731
38. Diebold B., Cohen A., Zelinsky R., et al. Is pulsed Doppler echocardiography an adequate method to evaluate left ventricular function during filling in hypertensive patients? Eur Heart J. 11:(Suppl G):1990;79-86